Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities

March 4, 2021 updated by: The University of Queensland

Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care

This project is a randomised trial in order to determine if "gamification" can result in behaviour change for healthcare workers in the residential aged care setting. The app is for Age Care and care workers at the front line who are working to protect those most vulnerable to COVID-19. There are 2 groups in this trial on group will receive current and accurate information from an app. The other group will receives the app with the addition of a gamification competent, this will include rewarding experiences for staff doing safety behaviours and wellbeing behaviours. The purpose of the gamification is to create a calming and reassuring experience that injects positivity and joy where possible during this stressful time.

Study Overview

Detailed Description

The study design will be a multi- centre cluster randomised control trial, where Age Care facilities are randomised into two groups:

  1. Newsfeed- gets the app with newsfeed only
  2. Gamification group- gets the full gamified app, including the newsfeed Workers in our network of residential aged care facilities will be invited to participate in a study of communication of information regarding COVID-19 and how they will play a role in preventing its spread.

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age Health Care Worker

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Newsfeed
This will provide you with reliable accurate information on the pandemic.
This will provide the user with reliable accurate information on the pandemic.
Experimental: Gamification
The gamification function will allow users to earn points for actions completed. The gamification function has links to resources for infection control, watching or completing tasks or playing games to earn points. Points can be viewed at a facility level, state level or national level.
This will provide the user with the newsfeed function and the addition of a gamification function

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare the hours of sick leave used over the course of the 4-week period post randomisation for each group
Time Frame: 4 weeks
Compare the number of sick leave prior to users utilising the app and at the end of the 4 weeks between the arms
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare handwashing behaviour
Time Frame: 4 weeks
Compare the amount of soap/sanitiser used between the arms
4 weeks
To compare self-testing rates
Time Frame: 4 weeks
Compare the number of self tests between the two arms
4 weeks
To compare the level of surface wipe down
Time Frame: 4 weeks
Compare the amount of wipes/disinfectant used between the two arms
4 weeks
To compare number of COVID-19 tests completed in Facilities
Time Frame: 4 weeks
Compare the number of COVID-19 tests between the two arms
4 weeks
To compare the number of COVID 19 infections in facilities
Time Frame: 4 weeks
Compare the number of COVID-19 infections between the arms
4 weeks
To compare the other types of outbreaks (Flu, gastroenteritis)
Time Frame: 4 weeks
Compare the number of flu and gastroenteritis outbreaks between the arms
4 weeks
To compare the awareness of COVID 19 training available to workers in the facilities
Time Frame: 4 weeks
Compare the COVID 19 training between the two arms, this is via a self reported survey
4 weeks
To compare the awareness of PPE training available to workers in the facilities
Time Frame: 4 weeks
Compare the awareness of PPE training of the workers in the two arms, this is captured in self reported survey
4 weeks
To compare the levels of PPE material used in
Time Frame: 4 weeks
Compare the amount of PPE used between the arms
4 weeks
To compare the wellbeing and self-efficacy of the two groups
Time Frame: 4 weeks
Compare the wellbeing and self-efficacy between the two arms, this is captured in a self reported survey.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David L Paterson, PhD, The University of Queensland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 6, 2020

Primary Completion (Actual)

August 26, 2020

Study Completion (Actual)

August 26, 2020

Study Registration Dates

First Submitted

May 4, 2020

First Submitted That Met QC Criteria

May 4, 2020

First Posted (Actual)

May 6, 2020

Study Record Updates

Last Update Posted (Actual)

March 9, 2021

Last Update Submitted That Met QC Criteria

March 4, 2021

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Care Collective Study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastroenteritis

Clinical Trials on Newsfeed function

3
Subscribe